Tango Therapeutics Inc., founded on May 21, 2020, and registered in Delaware, is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicines for cancer treatment. The company employs a patient-centric approach rooted in synthetic lethality genetics to identify and develop therapies targeting critical cancer drivers. This strategy expands the scope of precision oncology to new frontiers, such as addressing tumor suppressor gene loss and its role in how cancer cells evade immune cell attack. Company website: http://www.tangotx.com Company address: 201 Brookline Ave., Suite 901 Boston, MA 02215

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for TNGX via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.